 |
|
|
| |
CHARACTERIZATION OF SINGLE VERSUS DUAL ACTIVE MONOCLONAL ANTIBODIES AGAINST SARS-COV-2
|
| |
| |
CROI 2023 Feb 20-23
Manish C. Choudhary
Brigham and Women's Hospital | Harvard Medical School Boston, MA, USA
there are ongoing efforts to develop the next generation of mAbs and this study shows proof-of-principle that dual-active mAb therapy offers virologic benefit over single-active mAbs. This will help inform the design and implementation for future mAb therapeutics.
|
| |
|
|
|
|
|
